Highlights and Quick Summary
- Common Stock (Net) for the quarter ending May 31, 2022 was $606 Million (a 0.01% increase compared to previous quarter)
- Year-over-year quarterly Common Stock (Net) increased by 4.46%
- Annual Common Stock (Net) for 2021 was $580 Million (a 80.62% increase from previous year)
- Annual Common Stock (Net) for 2020 was $321 Million (a 34.25% increase from previous year)
- Annual Common Stock (Net) for 2019 was $239 Million (a 97.07% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Common Stock (Net) of Organigram Holdings Inc.
Most recent Common Stock (Net)of OGI including historical data for past 10 years.Interactive Chart of Common Stock (Net) of Organigram Holdings Inc.
Organigram Holdings Inc. Common Stock (Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $605.86 | $605.83 | – | – | – |
| 2021 | $573.7 | $580.0 | $602.54 | $383.88 | $580.0 |
| 2020 | $359.78 | $312.94 | $288.36 | $282.95 | $321.12 |
| 2019 | $240.68 | $239.96 | $228.24 | $171.72 | $239.19 |
| 2018 | – | – | $136.12 | $123.57 | $121.38 |
| 2017 | – | – | – | – | $78.51 |
| 2016 | – | – | – | – | $38.9 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic